Yiguanjian cataplasm attenuates opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome

被引:0
|
作者
Gao Shuai [1 ]
Gao Hong [2 ]
Fan Yuchen [1 ,3 ]
Zhang Guanghua [2 ]
Sun Fengkai [1 ]
Zhao Jing [1 ]
Li Feng [1 ]
Yang Yang [1 ]
Wang Kai [1 ,3 ]
机构
[1] Department of Hepatology,Qilu Hospital of Shandong University
[2] Institute of Hepatology,Shandong University
[3] Research Center for Material Evidence Identification,Shandong Public Security Bureau
关键词
Yi Guan Jian; Paste; Morphine; Nalox one; Opioid dependence;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
OBJECTIVE:To investigate the effect of Yiguanjian(YGJ) cataplasm on the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.METHODS:One hundred Swiss albino mice,of equal male to female ratio,were randomly and equally divided into 10 groups.A portion(3 cm2) of the backside hair of the mice was removed 1 day prior to the experiment.Morphine(5 mg/kg) was intraperitoneally administered twice daily for 5days.YGJ cataplasm was prepared and pasted on the bare region of the mice immediately beforemorphine administration on day 3 and subsequently removed at the end day 5.On day 6,naloxone(8mg/kg) was intraperitoneally injected to precipitate opioid withdrawal syndrome.Behavioral observation was performed in two 30-min phases immediately after naloxone injection.RESULTS:The YGJ cataplasm significantly and dose-dependently attenuated morphine-naloxone-induced experimental opioid withdrawal,in terms of withdrawal severity score and the frequencies of jumping,rearing,forepaw licking,and circling behaviors.However,YGJ cataplasm treatment did not alter the acute analgesic effect of morphine.CONCLUSION:YGJ cataplasm could attenuate opioid dependence and its associated withdrawal symptoms.Therefore,YGJ cataplasm could serve as a potential therapy for opioid addiction in the future.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 36 条
  • [1] Yiguanjian cataplasm attenuates opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome
    Gao Shuai
    Gao Hong
    Fan Yuchen
    Zhang Guanghua
    Sun Fengkai
    Zhao Jing
    Li Feng
    Yang Yang
    Wang Kai
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2016, 36 (04) : 464 - 470
  • [2] Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal
    Levin, Charles J.
    Wai, Jonathan M.
    Jones, Jermaine D.
    Comer, Sandra D.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [3] Phytotherapy of Opioid Dependence and Withdrawal Syndrome: A Review
    Tabatabai, Seyed Meghdad
    Dashti, Saeedeh
    Doosti, Fatemeh
    Hosseinzadeh, Hossein
    PHYTOTHERAPY RESEARCH, 2014, 28 (06) : 811 - 830
  • [4] Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice
    Li, Bing
    Jiang, Junyu
    Zhou, Li
    Tao, Xinrong
    Sun, Qixian
    Liu, Jiaxin
    Liu, Yang
    Pang, Gang
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 15
  • [5] Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice
    Lewter, Lakeisha A.
    Johnson, Marisa C.
    Treat, Anny C.
    Kassick, Andrew J.
    Averick, Saadyah
    Kolber, Benedict J.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2022, 100 (01) : 339 - 352
  • [6] Naloxone-induced morphine withdrawal increases the number and degranulation of mast cells in the thalamus of the mouse
    Taiwo, OB
    Kovács, KJ
    Sperry, LC
    Larson, AA
    NEUROPHARMACOLOGY, 2004, 46 (06) : 824 - 835
  • [7] Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized study
    Weisshaar, Stefan
    Brandt, Laura
    Litschauer, Brigitte
    Sheik-Rezaei, Safoura
    Moser, Laura
    Nirnberger, Guenther
    Kuehberger, Elisabeth
    Bauer, Ulrike
    Firbas, Christa
    Gouya, Ghazaleh
    Wolzt, Michael
    Fischer, Gabriele
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (08) : 1610 - 1619
  • [8] Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence
    Gery Schulteis
    Andrew C. Morse
    Jian Liu
    Psychopharmacology, 2004, 175 : 463 - 472
  • [9] Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence
    Liu, JA
    Schulteis, G
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 79 (01) : 101 - 108
  • [10] Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence
    Schulteis, G
    Morse, AC
    Liu, JA
    PSYCHOPHARMACOLOGY, 2004, 175 (04) : 463 - 472